Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups

In breve · dalla fonte (EU-Startups)

Di cosa si tratta

Sofinnova Partners, a Paris-based life sciences investor, has closed its Sofinnova MD Start IV fund at €82 million. The firm said the fund was oversubscribed and will build on a strategy dating back to 2008 that has created around a dozen companies. “Sofinnova MD Start is one of the few strategies in Europe focused on […] The post Sofinnova Partners closes oversubscribed €82 million MD Start IV fund to build new MedTech startups appeared first on EU-Startups .

Anteprima pubblicata dalla testata nel proprio feed. DuoBiz non ripubblica l'articolo né le immagini: per il testo completo, i dati e le dichiarazioni vai alla fonte.